Targeted Perioperative Haemodynamic Therapy Benefits Highest-Risk Surgical
A narrative review in the Journal of Anesthesia, Analgesia and Critical Care argues that goal-directed perioperative haemodynamic therapy has the clearest, most consistent benefit in the highest-risk surgical patients. The review notes that this group is about 12% of surgical cases but accounts for roughly 80% of perioperative mortality, from 4.5% in elective abdominal surgery to over 25% in emergencies. Synthesising trials and physiological frameworks, the authors link therapy to oxygen delivery and “oxygen debt” concepts. They report reduced major postoperative morbidity in high-risk patients, while intermediate-risk cohorts—especially with enhanced recovery pathways—show neutral outcomes. The review also aims to explore thresholds and the role of AI tools in 2026.






